Solid Biosciences (SLDB) Other Working Capital Changes (2017 - 2024)
Historic Other Working Capital Changes for Solid Biosciences (SLDB) over the last 8 years, with Q4 2024 value amounting to -$104000.0.
- Solid Biosciences' Other Working Capital Changes rose 7805.91% to -$104000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $976000.0, marking a year-over-year increase of 15625.36%. This contributed to the annual value of $2.4 million for FY2024, which is 435022.84% up from last year.
- According to the latest figures from Q4 2024, Solid Biosciences' Other Working Capital Changes is -$104000.0, which was up 7805.91% from $41659.0 recorded in Q3 2024.
- Over the past 5 years, Solid Biosciences' Other Working Capital Changes peaked at $22.2 million during Q4 2020, and registered a low of -$11.4 million during Q2 2022.
- Moreover, its 5-year median value for Other Working Capital Changes was -$459000.0 (2023), whereas its average is $13462.1.
- In the last 5 years, Solid Biosciences' Other Working Capital Changes surged by 49642.35% in 2020 and then plummeted by 35352.7% in 2021.
- Over the past 5 years, Solid Biosciences' Other Working Capital Changes (Quarter) stood at $22.2 million in 2020, then tumbled by 113.74% to -$3.0 million in 2021, then tumbled by 275.89% to -$11.4 million in 2022, then skyrocketed by 95.86% to -$474000.0 in 2023, then soared by 78.06% to -$104000.0 in 2024.
- Its Other Working Capital Changes was -$104000.0 in Q4 2024, compared to $41659.0 in Q3 2024 and $41659.0 in Q2 2024.